- Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN). Moiseyev, V.S., Põder, P., Andrejevs, N., Ruda, M.Y., Golikov, A.P., Lazebnik, L.B., Kobalava, Z.D., Lehtonen, L.A., Laine, T., Nieminen, M.S., Lie, K.I. Eur. Heart J. (2002)